A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings.
Psychiatry Research August 20, 2025 L. Mcinnes, Robert M. Berman, Matthew J Worley et al.
OBJECTIVE The study evaluated the effectiveness of Ketamine Intravenous Therapy (KIT) in reducing post-traumatic stress disorder (PTSD) and depression symptoms, using electronic health record data from outpatient psychiatric patients with PTSD. METHOD We analyzed data from 8,136 patients diagnosed with PTSD, 87 % (N = 7,070) of whom also had comorbid depression. Symptom severity was measured...